(PLRX) – Corporate News
-
Pliant Therapeutics Inc. (PLRX) Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
-
Pliant Therapeutics (PLRX) Reports Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PLRX Stock Lookup